Abstract: A device for delivering a cosmetic filler composition to the skin including a base carrying a plurality of hollow microneedles, in which each microneedle has an external largest transverse dimension less than or equal to 1500 micrometers, and the microneedles include a filler composition.

Abstract: A device including a base carrying a plurality of microneedles, and including at least one composition aimed at generating an in-situ reaction into the skin, scalp, or lips.

Abstract: The present invention relates to the field of preventive and/or curative protection of delicate lips. More precisely, a subject-matter of the invention is the cosmetic use of active principles which are capable of enhancing the content of ceramides in the lips, such as a ceramide precursor comprising a 6-hydroxy-4-sphingenine base, ascorbic acid or one of its analogues, as protective agent for delicate lips. The invention is additionally targeted at corresponding compositions for labial application.

Abstract: The present invention relates to the field of preventive and/or curative protection of delicate lips. More precisely, a subject-matter of the invention is the cosmetic use of active principles which are capable of enhancing the content of ceramides in the lips, such as a ceramide precursor comprising a 6-hydroxy-4-sphingenine base, ascorbic acid or one of its analogues, as protective agent for delicate lips. The invention is additionally targeted at corresponding compositions for labial application.

Abstract: The present invention concerns a non-therapeutic method to prevent and/or treat a skin in need of a calmative using a C-glycoside derivative.

Abstract: The present invention relates to a cosmetic method for improving and/or reinforcing the skin's barrier function comprising at least a step of applying to the skin a composition comprising at least one C-glycoside derivative.

Abstract: 7-Oxo-DHEA derivatives, various of which are themselves novel compounds, are well suited for cosmetically/therapeutically treating adverse conditions/afflictions of a keratinous substrate/material, notably of human skin, hair, eyelashes and nails, to improve the appearance thereof, in particular to prevent or treat signs of aging of the skin and/or a dull complexion and/or skin or hair pigmentation disorders and/or dryness of the skin and/or hyperseborrhoea and/or hyperseborrhoea-related imperfections and/or sensitive skin and/or dandruff and/or natural hair loss and/or baldness.

Abstract: 7-Oxo-DHEA derivatives, various of which are themselves novel compounds, are well suited for cosmetically/therapeutically treating adverse conditions/afflictions of a keratinous substrate/material, notably of human skin, hair, eyelashes and nails, to improve the appearance thereof, in particular to prevent or treat signs of aging of the skin and/or a dull complexion and/or skin or hair pigmentation disorders and/or dryness of the skin and/or hyperseborrhoea and/or hyperseborrhoea-related imperfections and/or sensitive skin and/or dandruff and/or natural hair loss and/or baldness.

Abstract: The present invention relates to the cosmetic use of 3&bgr;-acetoxy-7-oxo-DHEA to improve the appearance of keratin materials, with the exception of the treatment of wrinkles and fine lines, dry skin and dermatitis. This use is intended in particular for preventing or treating the loss of firmness of the skin and/or a dull complexion and/or dilation of the pores and/or skin or hair pigmentation disorders and/or hyperseborrhea and/or hyperseborrhea-related imperfections and/or sensitive skin and/or dandruff and/or hair loss and/or baldness.

Abstract: Stable, topically applicable water-in-oil emulsions, well suited for therapeutically treating irritated/sensitive skins and having high electrolyte content, comprise (a) at least 26 by weight of at least one water-soluble metal salt, (b) at least one hydrophobic gelling agent, (c) less than 5% by weight of at least one emulsifying agent, and, advantageously, at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc., and/or at least one keratolytic active agent, neuropeptide antagonist and/or inflammation-mediator antagonist.

Abstract: Stable, topically applicable water-in-oil emulsions, well suited for therapeutically treating irritated/sensitive skins and having high electrolyte content, comprise (a) at least 2% by weight of at least one water-soluble metal salt, (b) at least one hydrophobic gelling agent, (c) less than 5% by weight of at least one emulsifying agent, and, advantageously, at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc., and/or at least one keratolytic active agent, neuropeptide antagonist and/or inflammation-mediator antagonist.

Abstract: 7-Oxo-DHEA derivatives, various of which are themselves novel compounds, are well suited for cosmetically/therapeutically treating adverse conditions/afflictions of a keratinous substrate/material, notably of human skin, hair, eyelashes and nails, to improve the appearance thereof, in particular to prevent or treat signs of aging of the skin and/or a dull complexion and/or skin or hair pigmentation disorders and/or dryness of the skin and/or hyperseborrhoea and/or hyperseborrhoea-related imperfections and/or sensitive skin and/or dandruff and/or natural hair loss and/or baldness.

Abstract: A composition in the form of an oil-in-water (o/w) emulsion containing an oily phase dispersed in an aqueous phase, which contains a mixture of nonionic emulsifiers, the mixture being liquid at ambient temperature and having an HLB ranging from about 6 to 13, and in that the oily phase comprises at least about 5% by weight of one or more waxes based on the total weight of the composition, at least one of the waxes having a starting melting temperature of greater than or equal to about 50° C.

Abstract: A composition comprising urea and an N-substituted aminosulfonic acid. The composition may be used for the care, treatment and/or protection of human skin, mucous membranes and/or keratin fibers, in particular for moisturizing the skin and for the treatment of dry skin.

Abstract: Composition for containing at least 0.02% of at least one pentacyclic triterpenic acid and at least one emulsifier, liquid at 25° C., which is an optionally oxyalkylenated fatty acid monoester, having an HLB greater than or equal to 12 method of preparation.

Abstract: Combinatory antimicrobial immixtures comprising at least one antimicrobial hydrolipid and/or lipid and an antimicrobially synergistically effective amount of at least one glyceryl monoalkyl ether are well suited for formulation, as preservatives, into a wide variety of pharmaceutical/cosmetic compositions.

Abstract: Cosmetic compositions well suited for removing makeup from the skin and/or eyes, and/or for the cleansing thereof, include a cosmetically acceptable vehicle or carrier comprising a fatty phase and an aqueous phase, and further comprise (a) a polyethylene glycol diester and (b) a quaternary phosphate of formula (I): ##STR1## in which R is a cyclic, acyclic, aliphatic, aromatic or heterocyclic tertiary amine having at least 6 carbon atoms, X is an anion, A is an alkali metal, and x and y are two integers such that (x+y)=3, with the proviso that x cannot be zero.